Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
OnKure Therapeutics, Inc. (OKUR) had Stock-Based Compensation of $4.53M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-52.67M |
|
-- |
|
-- |
|
$54.39M |
|
$-54.39M |
|
$1.71M |
|
$-52.67M |
|
$-52.67M |
|
$-52.67M |
|
$-52.67M |
|
$-52.67M |
|
$-52.67M |
|
$-54.39M |
|
$-53.58M |
|
3.45M |
|
3.45M |
|
$-15.28 |
|
$-15.28 |
|
| Balance Sheet Financials | |
$113.00M |
|
$1.02M |
|
$1.90M |
|
$114.91M |
|
$10.53M |
|
-- |
|
$0.55M |
|
$11.08M |
|
$103.83M |
|
$103.83M |
|
$103.83M |
|
13.35M |
|
| Cash Flow Statement Financials | |
$-51.12M |
|
$15.87M |
|
$116.13M |
|
$29.88M |
|
$110.76M |
|
$80.89M |
|
|
Stock-Based Compensation |
$4.53M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-51.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.73% |
|
-50.73% |
|
-45.84% |
|
-50.73% |
|
$7.78 |
|
$-14.84 |
|
$-14.83 |
|